Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1232 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cellerant initiates leukemia drug trial

The open-label, multi-centre, dose escalation trial will assess the safety and tolerability of CLT-008 in the setting of chemotherapy-induced neutropenia. The trial will enroll approximately 30 evaluable patients

Cumberland Pharma introduces Acetadote injection

Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. The company has